This certification is available to: Regular Member, Retired, Early Career Physician, Associate, ASAM Staff, International Member, Emeritus Member, Provisional Member, Fellow Member, Honorary Member and CRT Member. Please log in to enroll.
ASAM's new Advanced Addiction Education Badge offers MD, DO, NP, and PA members formal recognition for completing 41 hours of advanced education across foundational and substance-specific topics. Designed as an option for those who may not be eligible for board certification, this digital badge highlights your commitment to evidence-based addiction care and lifelong learning. Launching in February 2026, the ASAM Advanced Addiction Education Badge will empower you to showcase your expertise to employers, colleagues, and patients alike.
Education Badge Courses:
Foundational
Review Course in Addiction Medicine (15 hours)
Pain & Addiction Essentials (6 hours)
Motivational Interviewing Essentials (4 hours)
Substance Specific
Treatment of Alcohol Use Disorder Course (4 hours)
Treatment of Opioid Use Disorder Course (8 hours)
Treatment of Stimulant Use Disorder (2 hours)
Treatment of Tobacco Use Disorder Course (2 hours)
Learners who have taken ASAM’s 8-hour Treatment of Opioid Use Disorder (TOUD) course (previously known as our waiver course) can upload their past certificate to take ASAM’s Advanced Buprenorphine instead. If you have not previously completed the 8-hour TOUD course, you are not eligible to take the Advanced Buprenorphine Course instead of the TOUD course. If you have any questions about this email ASAM at education@asam.org.
Other Requirements:
Participation in the badge is for MD, DO, NP and PA members only.
Learners must achieve a 75% or higher on each of the post-tests. Across all courses, there are a total of 160 CE questions.
Learners have 2 years to complete all 7 courses once they register for the Addiction Education Badge.
Any of these courses completed in the past 3 years can be counted towards the course requirements and are eligible to receive a discount.
Learners who have completed any of the required courses can email ASAM at education@asam.org to receive a discount toward enrollment in the education badge.
What is a Digital Badge?
A digital badge is a verified, shareable emblem that recognizes your advanced education in addiction medicine. Unlike a paper certificate, it’s a dynamic online marker of your expertise and easy to display on LinkedIn, your email signature, or your professional profile. Earning a digital badge helps you stand out to employers, colleagues, and patients as a leader committed to advancing evidence-based addiction care.
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$1050
Non-Member
Cannot Register
Associate Member
$800
Resident Member
$800
Student Member
Cannot Register
Membership Question? Call ASAM at 1.301.656.3920, email us or view the ASAM website for more information.
Participants have up to two years from their registration date to complete the badge requirements. Previously completed courses will be accepted if they were finished within three years prior to the registration date.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 2/18/2026
Instructions
Click on the Content tab to view all courses.
You must complete 6 required courses and 2 elective credits.
Elective credits can be obtained by completing the Treatment of Opioid Use Disorder Course.
If this course was taken before 2023, you will be required to upload your certificate and take Advanced Buprenorphine Education: Best Practices and Interactive Patient Cases instead.
Complete each course, including the accompanying post-tests and evaluations within two years of your registration date.
You will have 3 attempts to take each assessment and must score a 75% or above to pass.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
Email education@asam.org with the details of any fully completed courses to determine your eligibility for a discount. Partial course completions do not qualify, and a certificate must be available upon request.
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Accreditation & Credits
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Each course in this program is eligible for credits.
Please check the individual courses Credits and Disclosure tab for the types and amounts of credit.
This 15 hour, on-demand course is the essential primer for healthcare professionals preparing for the addiction medicine examination.
ASAM 2025 Review Course in Addiction Medicine
Recorded: Wednesday, July 23 - Thursday, July 24, 2025
On-Demand Course
Overview
The course offers 15 hours of on-demand lectures recorded from the ASAM 2025 Review Course in Addiction Medicine on Wednesday, July 23 to Thursday, July 24, 2025. The session topics are mapped to the addiction medicine exam blueprints and feature a highly accomplished group of faculty.
The ASAM Review Course in Addiction Medicine is the essential and foundational course for advanced practice providers who are preparing for the addiction medicine exam or for a career in addiction medicine. With a comprehensive curriculum, covering everything from neurobiology and pharmacology to individual substances and ethical concerns, the course offers a streamlined overview of addiction medicine delivered by an outstanding faculty lineup.
The target audience for this introductory and intermediate-level activity includes: Physicians preparing for the ABPM or AOA Board Certification Examination in addiction medicine, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This activity addresses all 6 ACGME Competencies: Patient Care and Procedural Skills, Medical Knowledge, Practice-Based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, and Systems-Based Practice.
Learning Objectives
Upon completion, participants should be able to:
Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$525
Non-Member
$699
Associate Member
$349
Resident Member*
$349
Student Member*
$349
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Open: 12/01/2025 - 11/01/2028
User Access Closed: 12/01/2028
Session Instructions
Click on the Contents tab to watch the on-demand recordings.
Click Complete Post Test after each of the four sections to answer multiple choice questions. You will have 3 attempts to pass and must earn a 75% on each post-test to proceed.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Paul Earley
MD, DFASAM
Dr. Paul Earley has been an Addiction Medicine Physician for 36 years. He treats all types of addictive disorders and specializes in the assessment and treatment of health care professionals. As a therapist, he works with patients already in recovery, providing long-term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. Dr. Earley is a Distinguished Fellow of ASAM and has been on the board of ASAM for over 20 years in several capacities. He has been the Medical Director of two nationally acclaimed addiction programs specializing in healthcare professionals who suffer from addiction illnesses. Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia in the U.S. With Earley Consultancy, LLC, he works with numerous treatment facilities, providing training in cohesive care, treatment effectiveness, and staff development.
Disclosures - Does Disclose:
DynamiCare Health, Inc. (Clinical Condition: Addiction Disorders): Ownership Interest includes stock, stock options, patent or other intellectual property, Stock
Earley Consultancy, LLC (Clinical Condition: All addiction Disorders): Employment
Georgia Professionals Health Program, Inc. (Clinical Condition: Addiction Disorders): Employment
Edwin Salsitz
MD, DFASAM
Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel , Division of Chemical Dependency, New York City, since 1983, and is an Associate Clinical Professor of Psychiatry at the Mount Sinai School of Medicine. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified in Addiction Medicine by the American Board of Preventive Medicine, as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.
Dr. Salsitz is a course director for ASAM sponsored Buprenorphine and REMS Opioid trainings, and is a lead mentor in the PCSS-MAT mentoring program. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine and Drug and Alcohol Dependence. He is the chair of the ASAM REMS course on safe and effective prescribing of opioids. Dr. Salsitz was the Co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee.
Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services. Dr. Salsitz is the recipient of the 2014 ASAM Annual Award, and the 2018 ASAM Annual Educator of the Year Award.
No Relevant Financial Disclosures
Ricardo Restrepo
MD, MPH
Ricardo Restrepo, MD, MPH finished his medical school in Medellín, Colombia. He then did his residency training in Psychiatry at Boston University Medical Center where he completed a fellowship in Addiction Psychiatry. He received an MPH in Global Public Health from NYU in 2008, while working at St Luke’s/Roosevelt Hospital, where he was Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York.
Since 2012, he works at the Long Beach VA Hospital, where he is the Medical Director of the SATP/Buprenorphine Clinic. Ricardo holds an academic position as Associate Clinical Professor of Psychiatry at the University of California (Irvine and Riverside) School of Medicine and most recently at the Charles Drew University, Los Angeles. He teaches and supervises students, psychiatry, family medicine and internal medicine residents. He serves as committee member of the American Academy of Addiction Medicine (AAAP) as well as on the California Society of Addiction Medicine (CSAM) Conference planning committee.
Ricardo's academic interests include the psychotherapy and psychopharmacology of addiction and the teaching of Psychiatry and Addiction Medicine. He is actively involved in issues related to transcultural psychiatry and behavioral addictions. He has worked with immigrant populations in the United States for over 20 years. As a volunteer for Physicians for Human Rights (PHR), he has participated in projects in the United States, Latin America and the Middle East. He has served as a United Nations Consultant since 2005.
Dr. Restrepo has written chapters on addiction and human rights textbooks. He is the co-author of textbooks on buprenorphine as well as women’s health and addiction, and he cooperated with the Translation of DSM-5 to Spanish. He is board re-certified in Psychiatry and Addiction Psychiatry and a professional musician.
No Relevant Financial Disclosures
Soteri Polydorou
MD
Soteri Polydorou, MD is a practicing physician with board certifications in Addiction Medicine and Internal Medicine. His involvement in the field of substance use disorder (SUD) treatment and education include serving as Medical Director of Addiction Services for Northwell Health and Associate Professor at the Zucker School of Medicine at Hofstra/Northwell. Northwell Health is a regional health system of over 20 hospitals and nearly 800 outpatient facilities. Dr. Polydorou is a member of various governmental and professional committees tasked with supporting the delivery and organization of addiction treatment. Dr. Polydorou’s interests include public policy initiatives to address substance use disorders, optimizing access to SUD services within health systems, and implementation of innovative opioid use disorder treatments within various healthcare clinical settings.
No Relevant Financial Disclosures
Jonathan Avery
MD
Jonathan Avery, MD is currently the Director of Addiction Psychiatry and an Associate Professor of Clinical Psychiatry at Weill Cornell Medical College and New York-Presbyterian Hospital. In addition to his clinical work, Dr. Avery teaches addiction psychiatry to the Weill Cornell medical students and residents of New York-Presbyterian Hospital. He has been published on a broad variety of topics in psychiatry, including papers on subjects ranging from clinician attitudes towards patients to how to use buprenorphine. He is the founder of the Addiction Stigma Institute that studies stigma towards individuals with substance use disorders and creates novel interventions to improve these stigmatizing attitudes. He was on the editorial board for the DSM-5 Clinical Cases book and is the editor of the books Co-occurring Mental Illness and Substance Use Disorders: A Guide to Diagnosis and Treatment and The Stigma of Addiction: An Essential Guide. He has won numerous awards for his clinical and academic work, including the American Board of Psychiatry and Neurology Faculty Innovation in Education Award and the Outstanding Faculty Member Award from the New York County Psychiatric Society.
No Relevant Financial Disclosures
Mashal Khan, MD
Attending of Clinical Psychiatry
NewYork Presbyterian Hospital-Weill Cornell
Dr. Mashal Khan is an Assistant Professor of Clinical Psychiatry at Weill Cornell Medicine-NewYork Presbyterian Hospital. He attended the School of Medicine at Xi'an Jiaotong University and trained at Maimonides Medical Center, where he served as Chief Resident. Following his residency training, he completed a Fellowship in Addiction Psychiatry at Icahn School of Medicine at Mount Sinai. He is board certified in General Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology. Dr. Khan works along with the the Liver transplant team and focuses on improving outcomes for individuals with alcohol use disorder and related liver disease.
Annie Levesque
MD, MSc, FASAM
Annie Levesque, MD, MSc, FASAM is the Medical Director of the Opioid Treatment Program at the Addiction Institute at Mount Sinai West. She is also the Associate Director of the Fellowship in Addiction Medicine Program at the Icahn School of Medicine at Mount Sinai. After receiving her medical degree from the University of Montreal, Dr. Levesque completed a Family Medicine and a Clinician-Scholar residency program at the University of Montreal, an Addiction Medicine fellowship at Mount Sinai West Hospital and a Masters in Experimental Medicine at McGill University
No Relevant Financial Disclosures
Faye Chao
MD
Faye Chao, MD is the unit chief of the inpatient addiction services at Mount Sinai West Hospital. She attended Jefferson Medical College in Philadelphia and completed her general psychiatry residency training at Harvard Longwood. She went on to an addiction psychiatry fellowship at NYU, and after fellowship, she worked at Bellevue Hospital for 1.5 years before moving on to her current position. She is board certified in both General and Addiction Psychiatry. Within the field of psychiatry, her interests include internet addiction and the management of pain in the addicted population.
No Relevant Financial Disclosures
Jeffrey DeVido, MD, MTS, FASAM, FAPA
Chief, Addiction Services//Behavioral Health Clinical Director
Marin County CA Dept of HHS//Partnership HealthPlan of CA
Jeffrey DeVido, MD, MTS, FASAM, FAPA is board certified in General Psychiatry, Addiction Psychiatry, and Addiction Medicine and works in Northern California. Upon completion of residency and fellowship training at Massachusetts General and McLean Hospitals/Partners Healthcare, he attended on the psychaitric consultation-liaison service at UCSF, Parnassus Campus for 3 years. For the past 5 years, Dr. DeVido has been Chief of Addiction Services with Marin County, CA, Department of Health and Human Services and Behavioral Health Clinical Director with Partnership HealthPlan of CA. In both of these roles, he is involved in managing the development of substance use and co-occurring services for Medicaid beneficiaries in 14 counties between the Oregon border and San Francisco. In his free time, he enjoys fly fishing, chasing around his 3 young kids, watercolor painting, Philadelphia sports, and Star Trek.
Financial Disclosures Nature of Relevant Financial Disclosure: Philip Morris/Altria: Equity Shareholder, from inheritance and Merck: Equity Shareholder, from inheritance
Leslie Hayes, MD
Family Physician
El Centro Family Health
Dr. Leslie Hayes, MD, works for El Centro Family Health in Espanola, NM. She is board-certified in both addiction and family medicine. While Dr. Hayes enjoys all aspects of family medicine, her particular passion is taking care of people with opioid use disorder. She especially enjoys working with pregnant women and new mothers who have had drug problems and works hard to make sure that they and their babies receive compassionate and appropriate medical care. She got much of her training in substance use disorders through Project ECHO and now considers herself extremely fortunate to have been able to give back to Project ECHO, and she now provides training for other providers around the state of New Mexico and nationally in substance use disorder and use of buprenorphine. She recently started an ECHO in her own organization with the goal of getting 90% of providers trained to prescribe buprenorphine and provide compassionate, evidence-based care for Substance Use Disorder. She was named a White House Champion of Change in April of 2016 for her work with substance use disorder and pregnancy. Her work was also featured in The Providers, an award-winning documentary about rural health care.
No Relevant Financial Disclosures
Lewis S. Nelson
MD
Dr. Nelson is Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School in Newark, NJ. He is a member of the Board of Directors of the American Board of Emergency Medicine and a Past-President of the American College of Medical Toxicology. He remains actively involved with CDC, FDA, DHS, and with several professional medical organizations including ASAM. Dr. Nelson is an editor of the textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several journals. In addition to providing direct clinical care to patient in the ED and his efforts at New Jersey Poison Information & Education System, his specific expertise include the consequences of licit and illicit opioids, emerging drugs of abuse, opioid stewardship, and alcohol withdrawal.
No Relevant Financial Disclosures
Carolyn Warner-Greer, MD, FACOG, FASAM
Medical Director
Bowen Center
Carolyn Warner-Greer, MD, FASAM is originally from Portland, Oregon. She is a graduate of Ball State University and Indiana University School of Medicine. She is board certified in obstetrics-gynecology and addiction medicine and currently is a physician at the Bowen Center and the medical director of the Bowen Recovery Center. She is the Immediate-Past President of the Indiana Chapter of the American Society of Addiction Medicine and speaks frequently on all topics of medical treatment of mental health and addiction recovery. She participates in Allen County Overdose Fatality Review Team, Indiana University School of Medicine Project ECHO as well as the Maternal Child Substance Use Disorder Network. She has worked extensively in forensic diversion as well as women’s health care and preventative community programming. She lives in Fort Wayne with her husband, Jerry, and their four children.
No Relevant Financial Disclosures
Mason Turner, MD, DFASAM
Associate Chief Medical Officer, Behavioral Health
Intermountain Health
Dr. Mason Turner is the Associate Chief Medical Officer for Behavioral Health for Intermountain Health based in Salt Lake City, UT and Denver, CO. His leadership in mental health care focuses on the development and evolution of strategic innovations in behavioral health care delivery that enhance quality of care and clinical excellence and are guided by principles of equity and inclusion of the patient/consumer voice into all aspects of the behavioral health ecosystem. Including integration initiatives which link mental health care and addiction medicine services with both primary and specialty medical care, as well as supporting innovative technological means of reaching patients for treatment of behavioral health conditions, he is also committed to enhancing access for behavioral health care services to all those who need it. Additionally, he has extensive experience in promoting employee health and well-being in a variety of corporate and healthcare sectors. As a clinician, he specializes in addiction medicine, consult-liaison psychiatry and treatment of personality disorders. He has received extensive training in resiliency-and systems-based approaches for improving the mental health and well-being of refugees, asylum seekers and torture survivors. Dr. Turner also served as a former Assistant Clinical Professor in Psychiatry at the University of California, San Francisco Medical School, where he taught medical students at all levels the practice of interviewing patients and clinical reasoning skills. He also served as adjunct faculty at the University of Hawaii John A. Burns School of Medicine. Dr. Turner earned his AB degree in psychology from Dartmouth College in Hanover, NH, and completed his MD degree at the University of Texas, Southwestern Medical Center/ Parkland Hospital in Dallas, TX. He completed his residency in psychiatry at Harvard University Medical School through Massachusetts General Hospital and McLean Hospital, in Boston, MA, with additional training in psychotherapy at the Center for Psychoanalytic Studies at Massachusetts General Hospital and addiction psychiatry at McLean Hospital. He is board certified in Psychiatry and Addiction Medicine through the American Board of Preventive Medicine.
No relevant disclosures
Michael Fingerhood, MD, FACP, DFASAM
Associate Professor of Medicine and Public Health
Johns Hopkins University
Dr. Michael Fingerhood is an Associate Professor of Medicine and Public Health at the Johns Hopkins University. He is the Chief of the Division of Chemical Dependence and medical director of the Comprehensive Care Practice (CCP) at Johns Hopkins Bayview Medical Center. The CCP integrates substance use disorder treatment with primary medical care, including care for HIV and hepatitis C.
No Relevant Financial Disclosures
Eve Lasswell
PsyD
UD San Diego Health
Eve Lasswell, PsyD, is a licensed clinical psychologist who treats adults with substance use and co-occurring disorders. Dr. Lasswell is part of UC San Diego Health's Addiction Recovery and Treatment Services, which uses a harm-reduction approach to provide care for all stages of recovery from substance use disorders. She treats patients with co-occurring mental health and substance abuse disorders and helps adults recover from addiction by encouraging behaviors that build wellness and emotional resilience.
In addition, she has experience helping people with post-traumatic stress disorder (PTSD), depression, and anxiety, as well as concerns related to role transitions and interpersonal relationships.
Dr. Lasswell also has experience providing care to diverse patient populations, including those with ethnic backgrounds different from her own, LGBTQIA (lesbian, gay, bisexual, transgender, queer or questioning, intersex, and asexual) individuals, and current and former members of the US military.
Her research aims to improve outcomes for people with substance use disorders and improving access to mental health services for the underserved.
Dr. Lasswell completed a postdoctoral fellowship in addiction treatment at Veterans Affairs Salt Lake City Health Care System. She earned her doctorate in clinical psychology at Indiana State University.
She is a member of the American Psychological Association's Society of Addiction Psychology.
No relevant financial disclosures
Amutha Rajagopal, MD, MPH
Physician
UC San Diego Health
Amutha Rajagopal, MD, is a board-certified internal medicine, infectious diseases and addiction medicine specialist. She is a part of UC San Diego Health's Owen Clinic, one of the nation's outstanding primary care centers for HIV positive individuals and consults in UC San Diego Health hospitals. Dr. Rajagopal also holds a master's degree in public health with an emphasis in epidemiology.
No relevant disclosures
David Kan, MD, DFASAM
Chief Medical Officer
Bright Heart Health
Dr. Kan graduated from Northwestern University Medical School. He finished his General Psychiatry Residency and Forensic Psychiatry Fellowship at the University of California, San Francisco (UCSF). He is Board-certified by the American Board of Psychiatry and Neurology in General and Forensic Psychiatry and he is Board-Certified by the American Board of Addiction Medicine in Addiction Medicine. He is a member of the faculty at the UCSF Department of Psychiatry.
Dr. Kan enjoys teaching, in addition to his direct work with patients. He has won multiple awards for teaching and clinical care delivery. Dr. Kan teaches and supervises psychiatrists-in-training in his role as a faculty member at UCSF. Throughout the year, he speaks at professional conferences on topics including treatment of addictive disorders.
Dr. Kan offers forensic consulting services to courts and attorneys in civil, criminal, and administrative matters. He has testified in multiple states, counties and federal court as an expert witness. He is a member of the American Academy of Psychiatry and the Law.
Dr. Kan works in private practice and is the Chief Medical Officer of Bright Heart Health. Bright Heart Health's mission is to provide high-quality addiction treatment via telemedicine to all.
Dr. Kan is an active member of the California Society of Addiction Medicine (CSAM). CSAM is a physician organization dedicated to improving the treatment of substance use disorders. Dr. Kan has planned conferences and spoken to many physician and non-physician groups. Dr. Kan is a Past President of CSAM. Dr. Kan is a Distinguished Fellow of the American Society of Addiction Medicine (D.F.A.S.A.M.).
Dr. Kan has testified numerous times before the California Assembly and Senate on addiction treatment. Dr. Kan has testified before Congress advocating for expanding access to addiction treatment.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Certified Counselors: NBCC Contact Hours Not OfferedAmerican Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 15 Medical Knowledge | 15 Patient Safety
ABP MOC: 15 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 15 Accredited CME
ABA MOCA 2.0®*: 15 Lifelong Learning | 15 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
Speakers disclosures are listed on the speakers tab.
This six-module on-demand course provides a comprehensive foundation in the integrated management of pain and addiction.
The ASAM Pain & Addiction Essentials Online
Updated: December 2025 Online Modules
Overview
This six-module on-demand course provides a comprehensive foundation in the integrated management of pain and addiction. Learners will explore the shared neurobiology of pain and substance use disorders, examine how stigma and bias impact patient care, and develop skills to identify and assess patients with or at risk for these conditions. The course highlights evidence-based pharmacologic and nonpharmacologic treatment approaches, emphasizing the importance of multimodal care. Learners will also gain strategies to enhance collaboration across disciplines and design coordinated, patient-centered treatment plans that address both chronic pain and substance use disorder effectively.
The target audience for this introductory series includes: primary care physicians, fellows in training and residents, providers who are new to addiction medicine or are early in their career and other members of the care team who are looking for introductory topics on pain and addiction.
This series addresses the following ACGME competencies: Patient Care, Medical Knowledge, Practice Based Learning, Interpersonal Skills, Professionalism, and Systems Based Practice.
Learning Objectives
Upon completion, learners will be able to:
Analyze how addiction and pain affect the brain and body, recognize factors that influence their development, and apply safe prescribing practices to support effective treatment.
Understand how stigma and bias influence the treatment of pain and substance use disorder and apply respectful language and evidence-based strategies to reduce their impact and improve patient outcomes.
Apply behavioral and evidence-based counseling approaches in collaboration with interdisciplinary teams to enhance motivation, support individualized care, and improve outcomes for individuals with opioid use disorder.
Integrate patient-centered communication, pharmacologic and non-pharmacologic strategies, and ongoing monitoring to support safe, multimodal treatment of pain and addiction.
Develop and apply multimodal, patient-centered treatment plans for pain and addiction by integrating nonpharmacological interventions, effective communication strategies, and appropriate referrals to support comprehensive, low-risk care.
Collaborate effectively within interdisciplinary teams to deliver multimodal, patient-centered care for pain and addiction by promoting communication, addressing barriers, and making appropriate referrals to support long-term management.
DEA Education Requirement
As an accredited organization in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets 6 hours of the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$145
Non-Member
$195
Associate Member
$95
Resident Member*
$95
Student Member*
$95
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Open Registration: 10/27/2025 - 11/01/2028
Close Access: 12/01/2028
Instructions
Click on the Contents tab to begin this activity.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 22 out of 29 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Donald R. Teater
MD, MPH
Don Teater MD, MPH is a family physician who has worked in western North Carolina for the past 30 years. Since 2004 he has focused on the intersection of pain, opioids, and addiction. Don was the lead facilitator for the expert panel during the development of the CDC Guidelines for Prescribing Opioids for Chronic Pain.
From 2013-2016, Don was the Medical Advisor at the National Safety Council leading their effort to reduce opioid abuse and overdose in the community and in the workplace. He continues to work with federal and state government organizations, medical organizations and nonprofits in addressing many aspects of the opioid epidemic.
While working on the public health aspects of the opioid epidemic, he sees patients one day a week treating opioid use disorder and chronic pain in Waynesville, NC by telemedicine. He also works one week each month as a pain and addiction specialist seeing Alaska Native patients with the SouthEast Alaska Regional Health Consortium (SEARHC) in Juneau, AK.
No Relevant Financial Disclosures
Launette Marie Rieb
MD, MSc, CCFP, FCFP, DABAM, FASAM
Launette Rieb, MD, MSc, CCFP, FCFP, DABAM, FASAM is a Clinical Associate Professor in the Department of Family Practice at the University of British Columbia (UBC), Canada. She is a Family Physician and diplomat of The American Board of Addiction Medicine. She did her graduate work in the area of pain physiology. She completed a postgraduate UBC Clinical Scholar's Program in 2015 and a NIDA sponsored Canadian Addiction Medicine Research Fellowship in 2016 resulting in publication on a newly described opioid pain phenomenon - withdrawal-associated injury-site pain (WISP). She has also published on fentanyl and heroin overdose deaths in BC, as well as on addiction in a variety of marginalized populations. Dr. Rieb is the Medical Director of a multidisciplinary team at OrionHealth (Vancouver Pain Clinic), and works as a consultant for the Rapid Access Addictions Clinic at St. Paul’s Hospital in Vancouver. In addition, she does addiction medicine consultations for The Orchard Recovery Centre, on Bowen Island. Dr. Rieb has taught addiction medicine in the undergraduate and postgraduate medical programs at UBC, and at national and international conferences for 24 years. Dr. Rieb was the co-creator and initial Physician Director of the St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship (now the BC Centre on Substance Use Addiction Medicine Fellowship). She is a member of the Canadian Society of Addiction Medicine’s Education Committee and the College of Family Physician of Canada's Competency Creation Working Group for the Certificate of Added Competency in Addiction Medicine. Dr. Rieb is the past recipient of a UBC Faculty of Medicine Post Graduate Teaching Award.
No relevant financial disclosures.
Maureen Boyle
PhD
Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) where she oversees ASAM’s quality improvement programs, publication development, and science initiative with the goal of supporting effective implementation of evidence based practices in the addiction treatment system.
Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).
Dr. Boyle has worked in the areas of research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), and the National Institute on Drug Abuse (NIDA). At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.
Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan; she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public; and she led development of research reports and other science communication materials.
No relevant financial disclosures.
Sarah Wakeman
MD, FASAM
Sarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, clinical co-lead of the Partners Healthcare Substance Use Disorder Initiative, and co-chair of the Partners Healthcare Opioid Steering Committee. She is the Chief Medical Officer of RIZE Massachusetts, a state-wide, private sector initiative created to build a $50 million fund to implement and evaluate innovative interventions to address the opioid overdose crisis.
She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine and board certified in Addiction Medicine by the American Board of Preventive Medicine. She is chair of the policy committee for the Massachusetts Society of Addiction Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she served as chair of the American Society of Addiction Medicine Drug Court Task Force and serves on their Ethics Committee.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, low threshold treatment models, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care.
No relevant financial disclosures
Anika Alvanzo
MD, MS, DFASAM, FACP
Anika Alvanzo, MD, MS, DFASAM, FACP is the Eastern Region Medical Director for Pyramid Healthcare, Inc. She also serves as a physician consultant on substance use disorders to the Behavioral Health Administration in the Maryland Department of Health and is the Managing Partner of Uzima Consulting Group, LLC, which provides addiction medicine-related consultation, education and training, and expert witness testimony. Dr. Alvanzo is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and Addiction Medicine. Dr. Alvanzo is a Distinguished Fellow of ASAM, a Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM), and currently serves as Chair of the ASAM Annual Conference Program Planning Committee and Region V Director for the ASAM Board of Directors.
At Pyramid Healthcare, Inc., Dr. Alvanzo’s role is to optimize and standardize the medical care, with emphasis on substance withdrawal management and pharmacotherapy, in the residential and outpatient addiction treatment programs in Eastern Pennsylvania and Maryland. Prior to this, Dr. Alvanzo spent twelve years as faculty in the Divisions of General Internal Medicine and Addiction Medicine at Johns Hopkins University School of Medicine where she held a variety of clinical leadership roles, including Associate Medical Director of Addiction Treatment Services and the Center for Addiction and Pregnancy and Medical Director of the Broadway Center for Addiction, comprehensive, outpatient substance use disorder treatment (SUD) programs on the Johns Hopkin Bayview and Johns Hopkins Hospital campuses, respectively. From 2011 – 2018, Dr. Alvanzo directed the Substance Use Disorders Consultation Service, a multidisciplinary addiction consultation service serving the Johns Hopkins Hospital Department of Medicine general and subspecialty services.
Dr. Alvanzo has served as an expert on National Institutes of Health (NIH), Substance Abuse and Mental Health Services Administration (SAMHSA), National Academies of Sciences, Engineering and Medicine (NASEM), National Quality Forum (NQF) and PEW Research Center panels regarding opioids and integration of recovery-oriented care in various medical settings.
No relevant financial disclosures
Matthew Tierney
APRN
Matt Tierney, APRN is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.
No relevant financial disclosures
Olivia Sinaiko
MA
Olivia Sinaiko, MA, is a behavioral health clinician with the Southeast Alaska Regional Health Consortium (SEARHC) in Juneau, AK. Olivia takes a trauma-informed, client-centered, and social justice-oriented approach to patient care, working with patients of all ages on a broad range of issues. A key focus in her work with clients is Pain Reprocessing Therapy (PRT), a form of therapy designed for patients with chronic pain. She offers a six-week pain neuroscience education program for people with chronic pain, as well as individual PRT therapy. Olivia graduated Phi Beta Kappa from Stanford University, with a B.A. in Philosophy. After earning a law degree from Yale Law School and completing a clerkship with the Alaska Supreme Court, she realized her true calling in supporting individuals, families, and communities as they navigate difficult transitions. Olivia returned to school for a master’s degree in counseling psychology from The Wright Institute.
Does Disclose - Ownership Interest (includes stock, stock options, patent or other intellectual property), Walgreens
Kari DeFreest
OTD, OTR/L, CHT
Kari is an occupational therapist and Pain Program manager with the Southeast Alaska Regional Health Consortium (SEARHC). Kari is passionate about empowering patients and providers through education and, in addition to her clinical practice, works with occupational therapy education programs and students to promote excellence in the next generation of therapy providers. Kari has clinical interests in rural health care, chronic pain management and hand therapy. Kari earned a bachelor of science degree in occupational therapy at Loma Linda University and doctorate in occupational therapy with a certificate in executive leadership at the University of St Augustine for Health Sciences.
Kari is passionate about bringing exceptional care to the residents of rural and remote communities. Kari has 30 years of clinical experience predominantly in rural health care settings as well as regulatory enforcement with the California Department of Public Health, Licensing and Certification Division.
No relevant financial disclosures
Gregory Rudolf
MD, DFASAM
Dr Rudolf is a physician board certified in addiction medicine, pain medicine, medical acupuncture and family medicine practicing at Swedish Pain Services in Seattle. The clinic integrates multidisciplinary pain care approaches in an effort to optimize patient functional outcomes and self-efficacy. He has also worked extensively in inpatient substance use disorder treatment settings and has published on the topic of opioid withdrawal management. He is the current Chair of the ASAM Pain and Addiction Committee, the immediate past president of the Washington Society of Addiction Medicine, and is a clinical associate professor at University of Washington.
No relevant financial disclosures
Aram Mardian, MD
Aram Mardian, M.D. is a clinical associate professor of Family, Community, and Preventive Medicine at the University of Arizona College of Medicine–Phoenix is a board-certified family physician and holds additional certifications in addiction medicine, pain medicine, and medical acupuncture. He is the founding Chief of the Chronic Pain Wellness Center at the Phoenix VA Health Care System, which models interprofessional whole-person care for patients with pain and opioid use disorder. Dr. Mardian serves as Co-Chair for the Arizona Pain and Addiction Curriculum Workgroup.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 6 Credits
Nurses & NPs: 6 Nursing Contact Hours
Pharmacology Hours: 1.5 Hours
PAs: 6 Credits
Pharmacists: 6 Credits
Interprofessional Continuing Education: 6 Credits
NBCC Contact Hours Not Offered
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 6 Medical Knowledge | 6 Patient Safety
ABA MOCA 2.0®*: 6 Lifelong Learning | 6 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
The complete list of disclosures and designation statements are linked below.
The ASAM Motivational Interviewing (MI) Essentials is a 4-hour online course designed for clinicians to practice skills that are consistent with motivational interviewer behaviors and to reflect on how to employ these skills in their clinical settings.
ASAM Motivational Interviewing Essentials
Overview
This four-hour course is a fully online course designed for clinicians to refresh their knowledge and practice skills that are consistent with motivational interviewing behaviors and to reflect on how to employ these skills in their clinical settings. The course is designed to help clinicians articulate the approach of motivational interviewing and apply it to conversations to promote positive change, and to practice skills consistent with motivational interviewing behaviors, reflecting on how to employ these skills in their clinical settings.
The target audience for this introductory level activity includes: physicians, clinicians, social workers, counselors, and all those speaking with patients with addiction wanting to expand their skillset towards helping their patients/clients change.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills, Practice-Based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
Articulate and enact the spirit of Motivational Interviewing (MI).
Identify the core features of MI congruent interactions.
Organize clinical communications attending to the four foundational tasks of MI (engaging, focusing, evoking, and planning).
Recognize change talk and apply the basic MI skills of open-ended questions, affirmations, reflective listening, and summaries to selectively reinforce change talk.
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$99
Non-Member
$139
Associate Member
$69
Resident Member*
$69
Student Member*
$69
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Open Registration: 03/01/2025 - 04/01/2028
Close Access Date: 5/1/2028
Instructions
Click on the Contents tab to begin this activity.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 12 out of 15 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Carla Marienfeld
MD, DFAPA, DFASAM
Carla Marienfeld, MD, is a board-certified addiction psychiatrist and Clinical Professor at the University of California, San Diego who supports recovery in an evidence based, harm-reduction approach through therapy, motivational interviewing, and medication treatment. Her research involves analysis of electronic medical record data for individuals with substance use disorders. She has authored or co-authored over 35 peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston.
Disclosures - Does Disclose:
Consultant and stock options: CARI Therapeutics
Brian Hurley
MD, MBA, DFASAM
Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. Brian is currently a Director at Large for the American Society of Addiction Medicine (ASAM) and will assume the position of President-Elect this April 2021. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Addiction Treatment Starts Here programs through the Center for Care Innovations, focused on increasing the delivery of Medications for Addiction Treatment in California’s community health centers. He is the PI of two MAT Access Points projects funded by the Sierra Health Foundation, a co-PI of a TRDRP funded smoking cessation implementation project, and a co-investigator on NIDA, NIAAA, and PCORI funded addiction related implementation science grants managed through RAND. He is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing trainings throughout the United States. He is a Volunteer Assistant Clinical Professor of Addiction Medicine in the Department of Family Medicine at the UCLA David Geffen School of Medicine. He additionally serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry examination writing committee.
Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a UCLA - Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed a fellowship program in addiction psychiatry at New York University School of Medicine. He completed residency training at the Massachusetts General Hospital and McLean Hospital, where he was Chief Resident in Addiction Psychiatry. Brian is a former National President of the American Medical Student Association.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 4 Credits
Nurses & NPs: 4 Nursing Contact Hours
PAs: 4 Credits
Social Workers: 4 Credits
Interprofessional Continuing Education: 4 Credits
Certified Counselors: 4 NBCC Contact HoursAmerican Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 4 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 4 Medical Knowledge | 4 Patient Safety
ABP MOC: 4 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 4 Accredited CME
ABA MOCA 2.0®*: 4 Lifelong Learning | 4 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventive Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This 4-hour introductory course provides an overview of the diagnosis and management of Alcohol Use Disorder, with a focus on treatment in both the inpatient and outpatient settings.
Treatment of Alcohol Use Disorder Course
Updated December 2025 Online Course
Overview
According to the 2021 National Survey of Drug Use and Health, 29.5 million people ages 12 and older had Alcohol Use Disorder in the past year. Alcohol Use Disorder is a chronic and complex disease that affects thousands of patients every year. There are evidence-based approaches to treatment, including non-pharmacological interventions and medications. Understanding these options and misconceptions about treatment alternatives can help improve outcomes for patients.
This 4-hour introductory course provides an overview of the diagnosis and management of Alcohol Use Disorder, with a focus on treatment in both the inpatient and outpatient settings. This case-based, interactive, asynchronous course highlights the triage and management of patients with alcohol withdrawal syndromes and the successful transition to evidence-based pharmacotherapy. Adjunct behavioral therapies will also be discussed.
The target audience for this introductory course is clinical healthcare professionals who prescribe medications in the outpatient or inpatient settings.
This course addresses the following ACGME Competencies: Patient Care, Procedural Skills and Medical Knowledge.
Learning Objectives
Demonstrate knowledge of nomenclature, diagnostic criteria, and the epidemiology of Alcohol Use Disorder (AUD)
Identify which people are appropriate for inpatient management vs. outpatient management of Alcohol Withdrawal Syndrome (AWS).
Discuss evidence-based methods of treatment for alcohol use disorder, including pharmacotherapy and behavioral treatments.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$99
Non-Member
$139
Associate Member
$69
Resident Member*
$69
Student Member*
$69
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 11/10/2028
User Access Closed: 12/1/2028
Acknowledgement
This activity was initially developed in 2023 with support from an unrestricted educational grant from Alkermes. No input or influence from Alkermes was included in the development of the original educational content per ACCME Standards for Integrity and Independence for Accredited Continuing Education. ASAM faculty have reviewed the content and made minimal updates where needed to ensure the content is reflective of any new evidence that has emerged since the course was initially developed.
Course Instructions
Click the Contents tab to begin the activity.
Complete the Course Overview and Modules 1-3.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 9 out of 12 questions correctly.
Click Complete Evaluation and Complete Presenter Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
For Pharmacists ONLY: Complete the task entitled "Enter Pharmacist CPE Monitor Information (Pharmacists Only)". Pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist CPE Monitor Information survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Stephen Holt, MD, MS, FACP, FASAM
Associate Professor of Medicine (General Medicine); Associate Program Director, Ambulatory Education
Yale School of Medicine
Dr. Holt has been an attending physician at Yale-New Haven Hospital since 2008 and is an Associate Professor of Medicine at Yale School of Medicine. He is the Director of the Yale Addiction Recovery Clinic and the Associate Program Director for Yale's Primary Care Internal Medicine Residency Program. He is board-certified in Addiction Medicine and Internal Medicine. He has published and lectures frequently on a variety of addiction medicine topics, and has won numerous teaching awards at the local, regional, and national level.
No relevant financial disclosures.
Shawn Cohen, MD
Addiction Medicine Doctor
Yale New Haven Hospital
Dr. Shawn Cohen is an addiction medicine doctor at Yale New Haven Hospital. He provides care on a hospital-based addiction consult service and is interested in lowering barriers to MOUD, improving the care of patients experiencing alcohol withdrawal, and making the hospital a more person-centered and less stigmatizing place for people who use substances.
No relevant financial disclosures.
Alyssa Peterkin
MD
Alyssa Peterkin, MD is an Instructor of Medicine Boston University School of Medicine and an internist at Boston Medical Center. Currently, she also serves as an associate program director for Grayken Addiction Medicine fellowship. She spends her clinical time working as a hospitalist, attending on the inpatient addiction consultation service and working in the substance use disorder urgent care. Her interests include educating learners at all levels and expanding access to addiction treatment.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 4 Credits
Nurses & NPs: 4 Nursing Contact Hours
Pharmacology Hours: 2 Hours
PAs: 4 Credits
Pharmacists: 4 Credits
Social Workers: 4 Credits
Interprofessional Continuing Education: 4 Credits
Certified Counselors: 4 NBCC Contact Hours
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 4 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 4 Medical Knowledge | 4 Patient Safety
ABA MOCA 2.0®*: 4 Lifelong Learning | 4 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity offers up to 4 CME credits, of which 4 credits contribute the patient safety CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
The complete list of disclosures and designation statements are linked below.
This 2-hour online course covers treating stimulant use disorder by using interactive, case-based learning to teach evidence-based practices.
Treatment of Stimulant Use Disorder Course
Created: September 2025 Online Course
Overview
The Treatment of Stimulant Use Disorder course is designed for healthcare professionals seeking to enhance their knowledge of available treatments and develop clinical skills for treating stimulant use disorder (StUD). This course will provide an exploration of StUD, equipping participants with the knowledge and tools to effectively engage and treat patients with StUD. Participants will examine the unique neurobiological and psychological features of stimulant addiction and distinguish it from other substance use disorders. They will explore evidence-based approaches, including behavioral interventions, emerging pharmacological treatments, and overdose prevention strategies.
The target audience for this introductory level activity includes: healthcare professionals, including physicians, psychologists, and addiction specialists, who provide care to patients with stimulant use disorder.
This activity addresses the following ACGME Competencies: Patient-centered Care, Medical Knowledge, Practice-based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, and Systems-based Practices.
Learning Objectives
Upon completion, learners will be able to:
Recognize the unique neurobiological and psychological characteristics of stimulant use disorder and differentiate it from other substance use disorders.
Recognize evidence-based behavioral intervention strategies for patients in stimulant use disorder treatment.
Implement pharmacological treatments for managing stimulant use disorder.
Utilize evidence-based overdose prevention strategies for patients in stimulant use disorder treatment.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$69
Non-Member
$99
Associate Member
$49
Resident Member*
$49
Student Member*
$49
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Open Registration: 08/11/2025 - 07/22/2028
Close Access Date: 08/11/2028
Instructions
Click on the Contents tab to begin this activity.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 6 out of 8 questions correctly.
Click Complete Evaluation and Complete Presenter Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Carla Marienfeld
MD, DFAPA, DFASAM
Carla Marienfeld, MD, is a board-certified addiction psychiatrist and Clinical Professor at the University of California, San Diego who supports recovery in an evidence based, harm-reduction approach through therapy, motivational interviewing, and medication treatment. Her research involves analysis of electronic medical record data for individuals with substance use disorders. She has authored or co-authored over 35 peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston.
Disclosures - Does Disclose:
Consultant and stock options: CARI Therapeutics
Brian Hurley
MD, MBA, DFASAM
Brian Hurley, MD, MBA, DFASAM is an addiction physician and the Director of Addiction Medicine for the Los Angeles County Department of Health Services. Brian is currently a Director at Large for the American Society of Addiction Medicine (ASAM) and will assume the position of President-Elect this April 2021. He co-chairs the Los Angeles County Department of Health Services’ Substance Use Disorders Workgroup and the SafeMedLA Medications for Addiction Treatment Action Team, and is the Clinical Director of the Addiction Treatment Starts Here programs through the Center for Care Innovations, focused on increasing the delivery of Medications for Addiction Treatment in California’s community health centers. He is the PI of two MAT Access Points projects funded by the Sierra Health Foundation, a co-PI of a TRDRP funded smoking cessation implementation project, and a co-investigator on NIDA, NIAAA, and PCORI funded addiction related implementation science grants managed through RAND. He is a member of the Motivational Interviewing Network of Trainers and regularly conducts motivational interviewing trainings throughout the United States. He is a Volunteer Assistant Clinical Professor of Addiction Medicine in the Department of Family Medicine at the UCLA David Geffen School of Medicine. He additionally serves on the American Board of Psychiatry and Neurology’s Addiction Psychiatry examination writing committee.
Brian completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California, Los Angeles (UCLA), and was previously a UCLA - Veterans Administration National Quality Scholar at the VA Greater Los Angeles Healthcare System. He completed a fellowship program in addiction psychiatry at New York University School of Medicine. He completed residency training at the Massachusetts General Hospital and McLean Hospital, where he was Chief Resident in Addiction Psychiatry. Brian is a former National President of the American Medical Student Association.
No relevant financial disclosures
Eve Lasswell
PsyD
UD San Diego Health
Eve Lasswell, PsyD, is a licensed clinical psychologist who treats adults with substance use and co-occurring disorders. Dr. Lasswell is part of UC San Diego Health's Addiction Recovery and Treatment Services, which uses a harm-reduction approach to provide care for all stages of recovery from substance use disorders. She treats patients with co-occurring mental health and substance abuse disorders and helps adults recover from addiction by encouraging behaviors that build wellness and emotional resilience.
In addition, she has experience helping people with post-traumatic stress disorder (PTSD), depression, and anxiety, as well as concerns related to role transitions and interpersonal relationships.
Dr. Lasswell also has experience providing care to diverse patient populations, including those with ethnic backgrounds different from her own, LGBTQIA (lesbian, gay, bisexual, transgender, queer or questioning, intersex, and asexual) individuals, and current and former members of the US military.
Her research aims to improve outcomes for people with substance use disorders and improving access to mental health services for the underserved.
Dr. Lasswell completed a postdoctoral fellowship in addiction treatment at Veterans Affairs Salt Lake City Health Care System. She earned her doctorate in clinical psychology at Indiana State University.
She is a member of the American Psychological Association's Society of Addiction Psychology.
No relevant financial disclosures
Siddarth Puri
MD
Sid Puri is an adult, child/adolescent, and addiction psychiatrist. He graduated from UC Davis School of Medicine and completed his adult psychiatry residency, served as chief resident for his child/adolescent fellowship, and addiction psychiatry fellowship at the UCLA Semel Institute. He’s currently the associate medical director of prevention at the Los Angeles County Department of Public Health, Bureau of Substance Abuse Prevention and Control (SAPC). He holds a BA and MA from UCLA in Art History and was a Fulbright Scholar to India.
No relevant financial disclosures
Stephen P. Murray, MPH, NRP
Director, SafeSpot Overdose Hotline / Adjunct Assistant Clinical Professor
rayken Center for Addiction at Boston Medical Center / Boston University School of Public Health Plymouth, Massachusetts
Stephen Murray, MPH, NRP, is an overdose researcher, Harm Reduction Program Manager and the Director of the SafeSpot Overdose Hotline at Boston Medical Center and an Adjunct Assistant Clinical Professor of Community Health Sciences at Boston University School of Public Health. In 2021, he retired as a Lieutenant at a large regional ambulance service in Western Massachusetts, and had served as a first responder since 2013, having worked both as a firefighter and paramedic. He regularly shares for a national audience about his lived experience as a person who used drugs and overdose survivor. Stephen provides expert technical assistance around the topics of overdose prevention, emergency medical services, workforce and harm reduction to a variety of organizations, county and state governments across the country, including the White House Office of National Drug Control Policy, Commonwealth of Massachusetts, Substance Abuse and Mental Health Services Agency, the National Academies of Medicine, and the National Governors Association. He has guest lectured at over a dozen universities including at Harvard University, University of Southern California, UMASS Medical School, and Georgetown University. He has research published in the International Journal of Drug Policy, Substance Use & Addiction Journal, American Journal of Public Health and Health Promotion Practice. In September 2023, he was featured in the multiple award-winning Episode 809 ("The Call") on This American Life.
No relevant financial disclosures
Raagini Jawa, MD, MPH, FASAM
Assistant Professor of Medicine
UPMC
Dr. Raagini Jawa is an Assistant Professor and Clinician Investigator in the Center for Research on Health Care, Department of General Internal Medicine at University of Pittsburgh Medical Center. She is board certified in Internal Medicine and Infectious Disease and Addiction Medicine. Dr. Jawa leads the Harm Reduction Research Collaborative team where her research focuses on the intersection of Infectious Disease and Addiction, including studying how to optimize integration of harm reduction services for individuals with substance use disorders within traditional health settings, developing multidisciplinary provider facing interventions to prevent infectious and non-infections complications of drug use. Clinically, she provides office-based addiction treatment in IM Recovery Engagement Program and attends the Endovascular Infection Service at UPMC.
No relevant financial disclosures
Dominick DePhilippis, PhD
Deputy National Mental Health Director for Substance Use Disorder
US Department of Veterans Affairs
Dr. DePhilippis is a licensed clinical psychologist with more than 30 years of experience as a clinician, researcher, and educator, predominantly, in the field of substance use disorders (SUD) treatment. He earned his Ph.D in Clinical Psychology in 1992 from Hahnemann University in Philadelphia, PA. He serves as the Deputy National Mental Health Director for Substance Use SUD in the Office of Mental Health in the US Department of Veterans Affairs (VA). He has particular interests and expertise in expanding access to evidence-based SUD treatment and measurement-based SUD care. He is a nationally recognized subject matter expert in Contingency Management (CM) whose work in implementing CM has been published in peer-reviewed scientific journals and featured in media reports in the New York Times, the Washington Post, Scientific American, and National Public Radio. He is a trainer in Motivational Interviewing and Cognitive Behavioral Therapy for Substance Use Disorders. Dr. DePhilippis also is a Member of the Motivational Interviewing Network of Trainers.
No relevant financial disclosures
Jeffery DeVido
MD, MTS, FASAM
Chief, Addiction Services//Behavioral Health Clinical Director Marin County CA Dept of HHS//Partnership HealthPlan of CA UCSF
Jeffrey DeVido, MD, MTS, FASAM is board certified in General Psychiatry, Addiction Psychiatry, and Addiction Medicine and works in Northern California. Upon completion of residency and fellowship training at Massachusetts General and McLean Hospitals/Partners Healthcare, he attended on the psychiatric consultation-liaison services at UCSF, Parnassus Campus for 3 years. For the past 7 years, Dr. DeVido has been Chief of Addiction Services with Marin County CA Department of Health and Human Services and Behavioral Health Clinical Director with Partnership HealthPlan of CA, while maintaining a volunteer faculty appointment at UCSF. In both of his roles with Marin County and Partnership HealthPlan, he is involved in managing the development of substance use and co-occurring services for Medicaid beneficiaries in 24 counties between the Oregon border and San Francisco. Dr. DeVido is also the primary editor of the soon-to-be-published 3rd Edition of the APA's Clinical Manual of Addiction Psychopharmacology. In his free time, he enjoys fly fishing, chasing around his 3 kids, watercolor painting, Philadelphia sports, and Star Trek.
Disclosures - Does Disclose:
Phillip Morris/Altria Shareholder From Inheritance; Merck and Co. Shareholder From Inheritance
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 2 Credits
Nurses & NPs: 2 Nursing Contact Hours
Pharmacology Hour(s): .75 Hour
PAs: 2 Credits
Interprofessional Continuing Education: 2 Credits
Certified Counselors: 2 NBCC Contact Hours
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 2 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 2 Medical Knowledge | 2 Patient Safety
ABP MOC: 2 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 2 Accredited CME
ABA MOCA 2.0®*: 2 Lifelong Learning | 2 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
The complete list of disclosures and designation statements are linked below.
This two-hour online course is designed to equip healthcare professionals with the knowledge and skills to confidently address tobacco use disorder in their patients.
Treatment of Tobacco Use Disorder in Clinical Practice
Created: September 2025
Online Course
Overview
This 2-hour course is designed for healthcare professionals seeking to strengthen their knowledge and clinical application of tobacco treatment. The course explores the historical, biological, and social foundations of Tobacco Use Disorder (TUD), and equips learners with tools for assessment, diagnosis, and treatment—including both pharmacologic and behavioral strategies. Learners will examine the relationship between TUD and co-occurring conditions, especially other SUDs, and learn to apply integrated care principles. Through case-based activities and practical resources, participants will gain the skills to support tobacco recovery in a wide range of healthcare settings.
The target audience for this course is healthcare professionals working with patients affected by tobacco use or co-occurring disorders.
This activity addresses the following ACGME Competencies: Patient-centered Care, Medical Knowledge, Practice-based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, and Systems-based Practices.
Learning Objectives
Upon completion, learners will be able to:
Apply an understanding of biological and social factors to develop effective, patient-centered engagement and care strategies for individuals with TUD.
Assess and diagnose TUD and communicate findings using person-centered, non-stigmatizing strategies.
Develop and tailor treatment plans that incorporate pharmacologic and behavioral interventions for individuals with TUD.
Implement integrated care strategies for TUD that address co-occurring conditions, withdrawal management, return to use prevention, and emerging treatments.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$69
Non-Member
$99
Associate Member
$49
Resident Member*
$49
Student Member*
$49
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Open Registration: 9/22/2025 - 08/26/2028
Close Access Date: 9/26/2028
Instructions
Click on the Contents tab to begin this activity.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 8 out of 10 questions correctly.
Click Complete Evaluation and Complete Presenter Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Peter Selby
MBBS, CCFP, FCFP, DFASAM
Dr. Peter Selby is a Senior Medical Consultant and Clinician Scientist at the Centre for Addiction and Mental Health (CAMH). He is the Vice-Chair, of Research, and Giblon Professor in Family Medicine Research, a University Named Professorship at the University of Toronto. He is also the Director of the Mental Health and Addictions Division in the Department of Family and Community Medicine, University of Toronto. His research focuses on innovative methods to understand and treat addictive behaviors and their comorbidities. He also uses technology to combine clinical medicine and public health methods to scale up and test health interventions.
He has received grant funding totaling over 100 million dollars from CIHR, NIH, and the Ministry of Health and has published >150 peer-reviewed publications. He has published 6 books (including 5 edited), is the author of 31 book chapters, and has 38 research reports prepared for the government. He is the Chair of the Medical Education Council for the American Society of Addiction Medicine. Dr. Selby mentors Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators, and medical students. The use of innovative methods to communicate messages makes Dr. Selby a sought-after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change at individual and system levels.
Does Disclose - Research support (in-kind products), Pfizer; Haleon; Kenvue
Stephen Baldassarri
MD, MHS
Dr. Baldassarri is an Assistant Professor of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine, at Yale School of Medicine. He completed his undergraduate medical education at Boston University School of Medicine and his residency and fellowship training at Yale School of Medicine. He is a physician Board Certified in Addiction Medicine, Pulmonary, Critical Care, and Lifestyle Medicine. He routinely cares for patients with substance use disorders in both inpatient and outpatient medical settings, and he conducts clinical research studies at the intersection between addiction and sleep. In his time outside of work, he enjoys spending time with family and friends, being physically active outdoors, and learning something new every day.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 2 Credits
Nurses & NPs: 2 Nursing Contact Hours
Pharmacology Hour(s): .50 Hour
PAs: 2 Credits
Pharmacists: 2 Credits Pharmacists must claim credits within 30 days and provide their eProfile ID and Birthdate. ASAM will not report credits claimed after 30 days or with incomplete information.
Social Workers: 2 Credits
Interprofessional Continuing Education: 2 Credits
Certified Counselors: 2 NBCC Contact Hours
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 2 Medical Knowledge | 2 Patient Safety
ABP MOC: 2 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 2 Accredited CME
ABA MOCA 2.0®*: 2 Lifelong Learning | 2 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
The complete list of disclosures and designation statements are linked below.
This 8-hour online course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices and also provides the required education needed to prescribe buprenorphine.
Treatment of Opioid Use Disorder Course
Updated: July 2024 Online Course
Overview
The ASAM Treatment of Opioid Use Disorder Course provides eight hours of education essential for providers to identify, assess, diagnose, and manage the treatment of patients with opioid use disorder (OUD). Through interactive and application-focused learning experiences, participants will explore misconceptions, stigma, and complexities associated with OUD and the use of medications to treat OUD, as well as how to address it for policies, systems, providers, and patients. Participants will gain an understanding of the epidemiology and neurobiology of opioid use disorder as well as opioid pharmacology, with a focus on medication-first treatment of OUD. Participants will examine medication and psychosocial treatment options and best practices for initiating and maintaining the treatment of OUD in hospital, office-based, and other outpatient settings. Emphasizing harm reduction or outcome-directed care, this course equips participants with the knowledge and skills to develop a low-threshold approach to the treatment of OUD. Learners will also explore the importance of collaborative care and provider partnerships with a focus on a holistic, team-based approach to treatment across the continuum of care for individuals with OUD.
The target audience for this introductory-level course includes: Physicians, Nurse Practitioners, Physician Associates, Nurses, Pharmacy and Pharmacy Technicians, Social Workers, Certified Counselors, Psychologists, Addiction Educators and Researchers, Students and Correctional Professionals and Peers.
The ACGME competencies include: Patient Care and Medical Knowledge.
Learning Objectives
Upon completion, learners will be able to:
Examine the underlying misconceptions, stigma, and complexities associated with opioid use disorder and the use of medications to treat opioid use disorder, and how to address it for policies, healthcare systems, providers, and patients.
Identify, assess, and diagnose patients with opioid use disorder, recognizing the potential role of medical and psychiatric comorbidities, policies, patient agency, and social determinants of health on a plan of care.
Develop a low threshold approach to the treatment of OUD with emphasis on harm reduction or outcome-directed care.
Develop a patient-centered treatment plan using a medication-first treatment approach.
Monitor progress and modify treatment plan based on patient needs and progress toward treatment goals.
Implement best practices for hospital settings, office systems, and other outpatient-based settings emphasizing team-based care to support treatment with medications for opioid use disorder.
Implement harm reduction best practices for individuals with opioid use disorder in a range of clinical settings.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that completion of this course meets the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$149
Non-Member
$199
Associate Member
$99
Resident Member*
$99
Student Member*
$99
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Open Registration: 07/01/2024 - 05/01/2027
Close Access Date: 06/01/2027
Instructions
Click on the Contents tab to begin this activity.
Click Complete Post Test to answer multiple choice questions. You will have 3 attempts to pass and must answer 17 out of 22 questions correctly.
Click Complete Evaluation and Complete Presenter Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Jeffrey P. Bratberg
PharmD, FAPhA
Dr. Bratberg studies the essential and emerging roles communitypharmacists play regarding opioid overdose, harm reduction and opioid usedisorder treatment. He advocates for pharmacists’ expanded roles in medicationaccess, public health promotion, and policy change through research, practice,and teaching. He is an associate editor of the Journal of the AmericanPharmacists Association (JAPhA) and co-produces and hosts a weekly publichealth pharmacy podcast with his pharmacy students, called “The Regimen.”
No relevant financial disclosures.
Daniel A. Nauts
MD, FASAM
Dr. Daniel A. Nauts, MD, FASAM, is an addiction medicine specialist who completed his undergraduate and medical education at the University of Michigan. He has developed numerous inpatient and outpatient substance use disorder (SUD) programs and medication for opioid use disorder (MOUD) services. As an independent contractor for the Montana Primary Care Association, he provides TOUD training, community forums on opioid use disorders, and strategies for tapering high-dose opioids. Active in the American Society of Addiction Medicine (ASAM), he supports physician and nurse health through Professional Assistance Programs and offers addiction medicine training for medical residents, APRN trainees, and PA students. Dr. Nauts is on the Drug Utilization Board of Mountain Pacific Quality Health and has held leadership roles within the Northwest Society of Addiction Medicine.
No relevant financial disclosures.
Kathryn M. Basques
MSW, MSN, APRN, PMHNP-BC
Kathryn M. Basques is a psychiatric nurse practitioner specializing in Addiction Medicine and Psychiatry. After completing her education at Yale School of Nursing, she started her career at Yale-New Haven Hospital on the first pro-active psychiatric consult service. From 2015-2020, she worked at Rush University Medical Center as the Co-Director of the Substance Use Intervention Team (SUIT) and dedicated herself to promoting the early identification of substance use disorders, implementation of an SBIRT model of care in the inpatient units, and improving the management of opioid and alcohol withdrawal syndromes. Since moving to Providence, RI, in 2021, Kathryn was first within the Lifespan Hospital System, continuing to work in a combined inpatient and outpatient, co-occurring clinical role. She is currently the Lead Psychiatry Provider for CODAC, an OTP and comprehensive substance use treatment program with locations throughout Rhode Island. Her areas of interest remain advocating for harm reduction policies in the treatment setting, motivational interviewing, and management of co-occurring syndromes.
No relevant financial disclosures.
J. Deanna Wilson
MD, MPH
Dr. Wilson is an Assistant Professor of Family Medicine andCommunity Health at the University of Pennsylvania. Shereceived her MD from Yale University School of Medicine and trained in internalmedicine and pediatrics at the Johns Hopkins University School of Medicine. Shecompleted additional subspecialty training in both adolescent and addictionmedicine also at Johns Hopkins. Dr. Wilson's research interests include reducingsubstance use-related health disparities and building equity, with an emphasis oninnovative strategies to treat opioid use disorders in adolescent and adultpopulations. Her work includes integrating harm reduction into primary caresettings, developing low threshold models of care to improve engagement andretention of vulnerable populations, and improving engagement and retention ofadolescents and young adults in OUD treatment.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 8 Credits
Nurses & NPs: 8 Nursing Contact Hours
PAs: 8 Credits
Pharmacology Hours: 3 Hours
Social Workers: 8 Credits
Pharmacists: 8 Credits
Interprofessional Continuing Education: 4 Credits
Certified Counselors: 8 NBCC Contact HoursAmerican Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 8 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 8 Medical Knowledge | 8 Patient Safety
ABP MOC: 8 Lifelong Learning & Self-Assessment
ABS Continuing Certification: 8 Accredited CME
ABA MOCA 2.0®*: 8 Lifelong Learning | 8 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventive Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
The complete list of disclosures and designation statements are linked below.
Qualifying ASAM Treatment Of Opioid Use Disorder Course certificate in order to access the Advanced Buprenorphine Education: Best Practices and Interactive Patient Cases.
Overview
Participants who completed the ASAM Waiver Course or Treatment of Opioid Use Disorder Course between 2001 and 2022 please upload your qualifying Treatment of Opioid Use Disorder Course certificate in order to access the Advanced Buprenorphine Education: Best Practices and Interactive Patient Cases. This course must have been taken through ASAM within the past three years. Certificates provided through other organizations are not acceptable.
How Does It Work?
Upon submitting your certificate, please allow 24-48 hours for your certificate to be reviewed. Upon approval, you will see a "pass" in the score field, allowing you to move to the next component. If your certificate is invalid, you will see "fail" in the score field. Reasons that you may receive a failing grade include submitting a certificate for the wrong course, a course completed more than three years from the date of submission, or a course from a certifying organization other than ASAM.
How to Access Your Course Certificate:
Login to your ASAM eLearning account
Click "My Dashboard" in the top menu bar
Select the blue "Advanced Search" button
Type "Opioid" in the search bar below "Filter by Title"
Advanced Buprenorphine Education: Best Practices and Interactive Patient Cases is a 4-hour self-paced course that equips clinicians with the latest evidence and practical tools for optimizing buprenorphine treatment in opioid use disorder (OUD).
Advanced Buprenorphine Best Practices and Interactive Patient Case
Created December 2025 Online Course
Overview
Advanced Buprenorphine Education: Best Practices and Interactive Patient Cases is a 4-hour self-paced course that equips clinicians with the latest evidence and practical tools for optimizing buprenorphine treatment in opioid use disorder (OUD). Through engaging, interactive modules and realistic patient cases, learners will deepen their understanding of best practices for initiation, stabilization, and maintenance in the era of high-potency synthetic opioids. Participants will apply decision-making frameworks to manage precipitated withdrawal, individualize dosing, and select between extended-release and sublingual formulations. By integrating these approaches across diverse patient scenarios, clinicians will strengthen their competence and confidence in delivering evidence-based, patient-centered OUD care.
The target audience for this advanced level course include: physicians, nurse practitioners/nurses, physician assistants, pharmacists, counselors, and other clinicians. Clinicians who see patients with addiction in primary care, emergency/urgent care, treatment center, or general psychiatry settings.
The ACGME competencies include: Patient Care and Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, and Systems-based Practice.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
Explain the pharmacologic principles and clinical implications of buprenorphine and other opioids relevant to opioid use disorder (OUD) treatment.
Analyze patient presentations to determine appropriate initiation strategies (traditional, low-dose, or high-dose) based on individual context.
Apply strategies to minimize patient discomfort and prevent or manage precipitated withdrawal during buprenorphine initiation.
Evaluate dosing approaches during stabilization and long-term maintenance to optimize outcomes and minimize the risk of return to use.
Differentiate the indications, benefits, and limitations of extended-release versus sublingual buprenorphine formulations.
Integrate patient-centered approaches to tailor treatment plans for complex clinical scenarios, such as fentanyl exposure, co-occurring pain, and prior treatment failures.
DEA Education Requirement
As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that the completion of this course counts toward meeting the DEA requirement for 8 hours of education on substance use disorder(s).
Registration Rates
ASAM Learner Type
Rate
ASAM Member
$99
Non-Member
$139
Associate Member
$69
Resident Member*
$69
Student Member*
$69
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate.Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Membership Question? Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.
Refunds & Cancellations
All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit.
Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 11/01/2028
Close Access Date: 12/01/2028
Acknowledgement
This activity was initially developed in 2023 with support from an unrestricted educational grant from Indivior. No input or influence from Indivior was included in the development of the original educational content per ACCME Standards for Integrity and Independence for Accredited Continuing Education. ASAM faculty have reviewed the content and made minimal updates where needed to ensure the content is reflective of any new evidence that has emerged since the course was initially developed.
Course Instructions
Click on the Contents tab to begin this activity. Complete all modules.
Click Complete Post Test to answer multiple choice questions. Participants will have 3 attempts to pass and must answer 17 out of 22 questions correctly.
Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org
ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Melissa B. Weimer
DO, MCR, FASAM
Melissa Weimer is board-certified in Internal Medicine and Addiction Medicine. She is an Associate Professor of Medicine and Public Health and Associate Program Director of the Addiction Medicine Fellowship at Yale University. She is an expert in hospital-based care for patients with substance use disorders and has worked with colleagues to develop successful hospital-based Addiction Medicine Consult Services at both Oregon Health & Science University and Yale University/Yale New Haven Hospital. Dr. Weimer is also a national leader in Addiction Medicine education and has developed curricula for substance use disorder evaluation and treatment and safe and effective pain treatment. Dr. Weimer serves on the national board of ASAM and is the Chair of the ASAM Clinical Practice Guidelines Methodology and Oversight Committee.
No relevant financial disclosures.
Stephen Holt
MD, MS, FACP, FASAM
Dr. Holt has been an attending physician at Yale-New Haven Hospital since 2008 and is an Associate Professor of Medicine at Yale School of Medicine. He is the Director of the Yale Addiction Recovery Clinic and the Associate Program Director for Yale's Primary Care Internal Medicine Residency Program. He is board-certified in Addiction Medicine and Internal Medicine. He has published and lectures frequently on a variety of addiction medicine topics, and has won numerous teaching awards at the local, regional, and national level.
No relevant financial disclosures.
Susan L. Calcaterra
MD, MPH, MS
University of Colorado School of Medicine
Dr. Susan Calcaterra is board-certified in Internal Medicine and Addiction Medicine and is an Associate Professor of Medicine at the University of Colorado School of Medicine. At the University of Colorado Hospital, she serves as the Medical Director of the Addiction Consultation Service and Associate Program Director of the Addiction Medicine Fellowship Program. Dr. Calcaterra's research on innovative methods to expand addiction treatment to hospitalized patients is funded by the National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA). Clinically, she practices hospital medicine and addiction medicine in the hospital setting.
No relevant financial disclosures.
Tiffany Lu, MD, MS, FASAM
Associate Professor of Medicine and Psychiatry
New York City Health & Hospitals - Jacobi / Albert Einstein College of Medicine
Dr. Tiffany Lu is the Associate Medical Director of Addiction Services at New York City Health & Hospitals/Jacobi, where she oversees the addiction consult service and outpatient addiction clinic, with an integrated opioid treatment program underway. Prior to joining Jacobi, Dr Lu was the Medical Director of Montefiore Medical Center's Buprenorphine Treatment Network and PI/PD of federal and municipal grant-funded initiatives to expand addiction care and education in general medical settings.
Dr. Lu is currently Associate Professor of Medicine and Psychiatry at the Albert Einstein College of Medicine as well as Education Chair and President-Elect for the NY Chapter of American Society of Addiction Medicine. She also serves on the Quality Improvement Council for ASAM. Dr. Lu graduated from UCSF School of Medicine, completed her Internal Medicine Residency at Massachusetts General Hospital, and holds a Master of Science in Clinical Research Methods from Albert Einstein College of Medicine.
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
Physicians: 4 Credits
Nurses & NPs: 4 Nursing Contact Hours
Pharmacology Hours: 2 Hours
PAs: 4 Credits
Pharmacists: 4 Credits
Social Workers: 4 Credits
Interprofessional Continuing Education: 4 Credits
Certified Counselors: 4 NBCC Contact Hours
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
NAADAC: 4 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
ABIM MOC Points: 4 Medical Knowledge | 4 Patient Safety
ABA MOCA 2.0®*: 4 Lifelong Learning | 4 Patient Safety MOCA 2.0® is a trademark of the American board of Anesthesiology®. This activity contributes to the CME requirement for Part II: Lifelong Learning and Self-Assessment of the American board of Anesthesiology's (ABA) redesigned Maintenance of Certification in Anesthesiology Program® (MOCA®), known as MOCA 2.0®. Please consult the ABA website, https://www.theaba.org/, for a list of all MOCA 2.0 requirements.
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
American Board of Addiction Medicine (ABAM)
American Board of Preventative Medicine (ABPM)
American Board of Psychiatry and Neurology (ABPN)
Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education. Speaker disclosures are listed on the speakers tab.
The complete list of disclosures and designation statements are linked below.
